Retroviral vector-mediated gene transfer into keratocytes: in vitro effects of polybrene and protamine sulfate

被引:0
|
作者
Berthold Seitz
Edwin Baktanian
Erlinda M. Gordon
W. French Anderson
Laurie LaBree
Peter J. McDonnell
机构
[1] Doheny Eye Institute,
[2] University of Southern California School of Medicine,undefined
[3] Los Angeles,undefined
[4] California,undefined
[5] USA,undefined
[6] Augenklinik mit Poliklinik der Universität Erlangen-Nürnberg,undefined
[7] Schwabachanlage 6,undefined
[8] D-91054 Erlangen,undefined
[9] Germany Tel. +49-9131-854477; fax +49-9131-854436; e-mail berthold.seitz@augen.med.uni- erlangen.de,undefined
[10] Departments of Pediatrics and Biochemistry,undefined
[11] University of Southern California School of Medicine,undefined
[12] Los Angeles,undefined
[13] California,undefined
[14] USA,undefined
[15] Department of Preventive Medicine,undefined
[16] University of Southern California School of Medicine,undefined
[17] Los Angeles,undefined
[18] California,undefined
[19] USA,undefined
关键词
Protamine; Transduction Efficiency; Morphological Sign; Protamine Sulfate; Corneal Wound;
D O I
暂无
中图分类号
学科分类号
摘要
· Background: To determine the potential of somatic gene transfer as a novel technique for modulating corneal wound healing on a cellular level, the successful transduction of human keratocytes should be ascertained in vitro. In addition, the ability of different polycations to increase the transduction efficiency and their antiproliferative and cytotoxic effects should be assessed. · Methods: To test transduction efficiency (X-Gal staining), cultured human keratocytes were incubated for 2 h with a retroviral vector bearing the β-galactosidase gene, with and without the addition of polybrene or protamine sulfate. To test the antiproliferative and cytotoxic effects, cultured human keratocytes were incubated with various concentrations of polybrene and protamine sulfate (0.08 to 800 μg/ml) for 2, 24 and 72 h, and evaluations were performed by means of an XTT-based colorimetric assay and phase-contrast microscopy. · Results: Human keratocytes in vitro were transduced successfully with the ß-galactosidase gene (3.5±1.0%). Transduction efficiency was significantly (P≤0.01) improved by addition of a polycation (from 12.3±1.7% to 18.6±2.3%), but there was no significant difference between the effects of polybrene and those of protamine sulfate. Both drugs induced a highly significant dose-dependent inhibition of proliferation (P<0.001). ID50 ranged from 11 to 22 μg/ml with polybrene and from 15 to 244 μg/ml with protamine sulfate. Only with doses of 80 and 800 μg/ml did protamine sulfate produce less antiproliferative effects than polybrene (P≤0.04). The lowest concentrations induced no morphological signs of cytotoxicity, whereas these signs were mild at 8 μg/ml and moderate to severe at the highest concentrations. · Conclusions: Both polybrene and protamine sulfate can significantly improve the in vitro efficiency of successful retroviral vector-mediated gene transfer into keratocytes. Mild cytotoxic and moderate antiproliferative effects are to be expected in cultured keratocytes with a standard transduction procedure (8 μg/ml for 2 h).
引用
收藏
页码:602 / 612
页数:10
相关论文
共 50 条
  • [31] AAV vector-mediated gene transfer to the brain of the cat
    Vite, CH
    Passini, MA
    McGowan, JC
    Poptani, H
    Polesky, AC
    Chambers, B
    O'Donnell, P
    Salvetti, A
    Haskins, ME
    Wolfe, JH
    MOLECULAR THERAPY, 2003, 7 (05) : S93 - S93
  • [33] Adenovirus vector-mediated gene transfer into stem cells
    Kawabata, Kenji
    Sakurai, Funlinori
    Koizumi, Naoya
    Hayakawa, Takao
    Mizuguchi, Hiroyuki
    MOLECULAR PHARMACEUTICS, 2006, 3 (02) : 95 - 103
  • [34] Vector-Mediated Antibody Gene Transfer for Infectious Diseases
    Schnepp, Bruce C.
    Johnson, Philip R.
    GENE THERAPY FOR HIV AND CHRONIC INFECTIONS, 2015, 848 : 149 - 167
  • [35] Viral vector-mediated gene transfer for CNS disease
    Snyder, Brooke R.
    Boulis, Nicholas M.
    Federici, Thais
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2010, 10 (03) : 381 - 394
  • [36] Therapeutic effects of viral vector-mediated antiangiogenic gene transfer in malignant ascites
    Hampl, M
    Tanaka, T
    Albert, PS
    Lee, JW
    Ferrari, N
    Fine, HA
    HUMAN GENE THERAPY, 2001, 12 (14) : 1713 - 1729
  • [37] Retroviral vector-mediated gene therapy for hemophilia B mice and dog.
    Xu, LF
    Sands, MS
    Nichols, TC
    Gao, CH
    Raymer, RA
    Ponder, KP
    BLOOD, 2002, 100 (11) : 20A - 20A
  • [38] Retroviral vector-mediated neonatal gene therapy for hemophilia a mice and dogs.
    Xu, LF
    Nichols, TC
    Sarkar, R
    McCorquodale, S
    Bellinger, D
    Ponder, KP
    BLOOD, 2003, 102 (11) : 53A - 53A
  • [39] Protamine sulfate enhances lipid-mediated gene transfer
    Sorgi, FL
    Bhattacharya, S
    Huang, L
    GENE THERAPY, 1997, 4 (09) : 961 - 968
  • [40] Efficient In Vivo xenogeneic retroviral vector-mediated gene transduction into human hepatocytes
    Emoto, K
    Tateno, C
    Hino, H
    Amano, H
    Imaoka, Y
    Asahina, K
    Asahara, T
    Yoshizato, K
    HUMAN GENE THERAPY, 2005, 16 (10) : 1168 - 1174